Description

1,2,3,6-Tetrahydro-1,3-Dimethyl-2,6-Dioxo-7H-Purine-7-Acetic Acid, Compound With [R-(R,S)]-α-[1-(Methylamino)Ethyl]Benzyl Alcohol (1:1) is a high-purity pharmaceutical intermediate and active ingredient complex. This compound is critical for ensuring the quality and efficacy of downstream pharmaceutical formulations. It is primarily utilized by research institutions and manufacturers in the pharmaceutical industry for the development and production of advanced therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of complex active pharmaceutical ingredients (APIs).
• Active Ingredient Synthesis: Used in the research and development of new therapeutic compounds, particularly in specialized drug classes.
• Biochemical Research: Serves as a reference standard or reagent in pharmacological and metabolic studies.
• Process Chemistry: Employed in scale-up and optimization of manufacturing processes for pharmaceutical production.
• Analytical Standard: Provides a high-purity benchmark for quality control and analytical method development in laboratories.

Basic Information

Product Name	1,2,3,6-Tetrahydro-1,3-Dimethyl-2,6-Dioxo-7H-Purine-7-Acetic Acid, Compound With [R-(R,S)]-α-[1-(Methylamino)Ethyl]Benzyl Alcohol (1:1)
CAS No.	29701-08-4
Molecular Formula	C18H25N5O5
Molecular Weight	391.42 g/mol
Synonyms	Pentoxifylline Related Compound A (EP Impurity A); 1-(5-Hydroxyhexyl)-3,7-dimethylxanthine salt; 3,7-Dimethyl-1-(5-oxohexyl)xanthine compound; HWA 285; BL 191; Oxpentifylline impurity; 1H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, compd. with α-[1-(methylamino)ethyl]benzenemethanol (1:1); [R-(R*,S*)]-α-[1-(Methylamino)ethyl]benzenemethanol compound with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione-7-acetic acid (1:1)
EINECS	Contact for details

Quality Control

Our 1,2,3,6-Tetrahydro-1,3-Dimethyl-2,6-Dioxo-7H-Purine-7-Acetic Acid, Compound With [R-(R,S)]-α-[1-(Methylamino)Ethyl]Benzyl Alcohol (1:1) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC and spectroscopic methods, to ensure compliance with pharmaceutical-grade standards and relevant pharmacopoeial monographs (e.g., EP, USP). A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed after opening to minimize exposure to atmospheric moisture and light.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any individual impurity ≤ 0.5%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.